
Losartan may stimulate brown fat, preclinical Rockefeller study suggests
Rockefeller researchers report that the blood pressure drug losartan, an angiotensin receptor blocker, may stimulate brown fat. Brown fat is linked to better insulin sensitivity and lower diabetes and cardiovascular risk. The link between ARBs and brown fat was first found in an analysis of over 100,000 patients, and this study is preclinical.
